Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients

BACKGROUND: Kidney transplant recipients (KTR) are at increased risk of cancer due to chronic immunosuppression. Non-melanoma skin cancer has an excess risk of approximately 250 times higher than the general population. Moreover, in solid organ transplant recipients (SOTR) these cancers have a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Meerhaeghe, T., Baurain, J.F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., Aspeslagh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479765/
https://www.ncbi.nlm.nih.gov/pubmed/37675002
http://dx.doi.org/10.3389/fneph.2022.1041819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479765/
https://www.ncbi.nlm.nih.gov/pubmed/37675002
http://dx.doi.org/10.3389/fneph.2022.1041819

Ejemplares similares